The judges’ decision allows exceptions that may permit scientists’ travel from the blocked countries.

David Schwartz of the Illinois Institute of Technology-Chicago, Kent College of Law, discusses the impact of the US Supreme Court unanimously striking down Myriad Genetics' patent of human BRCA genes and tests to detect mutations in them.

How the US government impacted life science research in 2013

Overstating the benefits of a drug lands a former biotech executive in home detention.

August 2013's selection of notable quotes

Myriad Genetics, the company originally behind tests for the cancer-associated BRCA mutations, is suing two competitors for patent infringement.

July 2013's selection of notable quotes

Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.

The scientific community and the impact of the Myriad Genetics Supreme Court decision

Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration

The Justices have decided that isolated sequences of human DNA are not eligible for patent protection, but rules that artificial sequences can be patented.
 

Top justices rule that police have the right to take DNA swabs from people who are arrested, even before they are convicted.

The justices unanimously upheld Monsanto’s patent rights on Roundup Ready seeds.

A decision will not be reached until later in the year, but the United States’ top justices appear to be inclined to rule against the validity of patenting human genes.

In an upcoming hearing, the US Supreme Court will decide on whether police can take DNA samples from suspects who have not been convicted.

The highest court in the country has declined to hear an appeal regarding the federal funding of human embryonic stem cell research, allowing such spending to continue.

Scientists fighting the federal funding of human embryonic stem cell research bring their case before the country’s highest court.

New Jersey judges are now required to explain to jurors that the human memory is prone to errors.

James Watson files a brief in the ongoing legal case over Myriad Genetics’ right to hold patents on the BRCA1 and BRCA2 genes.